← Leaderboards
Yingbin Fu
University Of Utah
$5,386,081
Attributed
$8,222,357
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,222,357 · 4
By mechanism
R01$4,440,656 · 3
U24$3,781,701 · 1
Top collaborators
- Takeshi Iwata4 shared
- Michiko Mandai4 shared
- Tetsushi Sakuma2 shared
- Takashi Yamamoto2 shared
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignMouse ModelMutantRetinaLeadMediatingStructure Of Retinal Pigment EpitheliumInhibitor/AntagonistPreventPharmaceutical PreparationsPathologicDisease ProgressionPhenotypeS AmaurosisRetinal DegenerationPhotoreceptor DegenerationGenesGenerationsInheritedReportingLeber&AposMacrophageCytokineBlindness
Grant awards (17)
Mechanistic study and therapeutic application of AIBP in AMD$400,150
R01 · FY2025 · EY · contact PI
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy$835,442
U24 · FY2024 · EY · contact PI
Mechanistic study and therapeutic application of AIBP in AMD$405,433
R01 · FY2024 · EY · contact PI
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy$960,512
U24 · FY2023 · EY · contact PI
Mechanistic study and therapeutic application of AIBP in AMD$409,867
R01 · FY2023 · EY · contact PI
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy$948,200
U24 · FY2022 · EY · contact PI
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy$1,037,547
U24 · FY2021 · EY · contact PI
Mechanisms and treatment strategies for polypoidal choroidal vasculopath$407,803
R01 · FY2016 · EY · contact PI
Cone opsin in photoreceptor degeneration$393,336
R01 · FY2016 · EY · contact PI
Cone opsin in photoreceptor degeneration$399,801
R01 · FY2015 · EY · contact PI
Mechanisms and treatment strategies for polypoidal choroidal vasculopath$223,865
R01 · FY2015 · EY · contact PI
Mechanisms and treatment strategies for polypoidal choroidal vasculopath$141,185
R01 · FY2015 · EY · contact PI
Mechanisms and treatment strategies for polypoidal choroidal vasculopath$372,500
R01 · FY2014 · EY · contact PI
Cone opsins in photoreceptor degeneration$365,050
R01 · FY2014 · EY · contact PI
Mechanisms and treatment strategies for polypoidal choroidal vasculopath$194,250
R01 · FY2014 · EY · contact PI
Cone opsins in photoreceptor degeneration$353,875
R01 · FY2013 · EY · contact PI
Cone opsins in photoreceptor degeneration$373,541
R01 · FY2012 · EY · contact PI